Brolucizimab-leading an era of structural revolution for long-term VEGF suppression

被引：21
作者：
Sharma, Ashish [1 ]
Kumar, Nilesh [1 ]
Kuppermann, Baruch D. [2 ]
Bandello, Francesco [3 ]
机构：
[1] Lotus Eye Hosp & Inst, Dept Vitreoretina, Coimbatore, Tamil Nadu, India
[2] Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA USA
[3] Univ Vita Salute Sci Inst San Raffaele, Dept Ophthalmol, Milan, Italy
来源：
EYE | 2020年 / 34卷 / 04期
关键词：
ABICIPAR-PEGOL;
D O I：
10.1038/s41433-019-0583-z
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：611 / 613
页数：3
相关论文
共 13 条
[1]   Targeting VEGF in eye neovascularization: What's new? A comprehensive review on current therapies and oligonucleotide-based interventions under development [J].
Amadio, Marialaura ;
Govoni, Stefano ;
Pascale, Alessia .
PHARMACOLOGICAL RESEARCH, 2016, 103 :253-269
[2]   David vs. Goliath: The Structure, Function, and Clinical Prospects of Antibody Fragments [J].
Bates, Adam ;
Power, Christine A. .
ANTIBODIES, 2019, 8 (02)
[3]   Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration [J].
Callanan, David ;
Kunimoto, Derek ;
Maturi, Raj K. ;
Patel, Sunil S. ;
Staurenghi, Giovanni ;
Wolf, Sebastian ;
Cheetham, Janet K. ;
Hohman, Thomas C. ;
Kim, Kimmie ;
Lopez, Francisco J. ;
Schneider, Susan .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, 34 (10) :700-709
[4]  
Dugel P.U., 2019, Ophthalmology
[5]   PEGylation: An approach for drug delivery. A review [J].
Jain, Aviral ;
Jain, Sanjay K. .
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2008, 25 (05) :403-447
[6]   Role of the Fc Region in the Vitreous Half- Life of Anti-VEGF Drugs [J].
Joo, Kwangsic ;
Park, Sang Jun ;
Choi, Yewon ;
Lee, Jung Eun ;
Na, Young Mi ;
Hong, Hye Kyoung ;
Park, Kyu Hyung ;
Kim, Ho Min ;
Chung, Jae-Yong ;
Woo, Se Joon .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (10) :4261-4267
[7]   Development of Anti-VEGF Therapies for Intraocular Use: A Guide for Clinicians [J].
Keane, Pearse A. ;
Sadda, Srinivas R. .
JOURNAL OF OPHTHALMOLOGY, 2012, 2012
[8]   Antibody Fragments as Potential Biopharmaceuticals for Cancer Therapy: Success and Limitations [J].
Kholodenko, Roman, V ;
Kalinovsky, Daniel, V ;
Doronin, Igor I. ;
Ponomarev, Eugene D. ;
Kholodenko, Irina, V .
CURRENT MEDICINAL CHEMISTRY, 2019, 26 (03) :396-426
[9]   Production of an anti-Aβ antibody fragment in Pichia pastoris and in vitro and in vivo validation of its therapeutic effect [J].
Montoliu-Gaya, Laia ;
Esquerda-Canals, Gisela ;
Bronsoms, Silvia ;
Villegas, Sandra .
PLOS ONE, 2017, 12 (08)
[10]   Improved pharmacokinetics of recombinant bispecific antibody molecules by fusion to human serum albumin [J].
Mueller, Dafne ;
Karle, Anette ;
Meissburger, Bettina ;
Hoefig, Ines ;
Stork, Roland ;
Kontermann, Roland E. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (17) :12650-12660
12